Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Nov 16, 2019; Nashville, TN, USA; Kentucky Wildcats fans carry a beer cup chain to the front row during the second half ...
“So, it’s exciting, it’s going to be… fun!” One of the mash tuns seen through an opening in the 1888 mill extension. Picture: John Davidson • For just £10 for the first year you can get unlimited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback